Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy and Tolerability of the APD Treatment in PAED Patients
Sponsor: Fresenius Medical Care Deutschland GmbH
Summary
The Silencia PD (peritoneal dialysis) cycler offers a pediatric (PAED) mode with advanced features such as Time and Volume Optimization (TAVO), supporting precise and individualized treatment. This study evaluates the efficacy and tolerability of Automated Peritoneal Dialysis (APD) using the Silencia PD cycler in patients weighing ≤ 20 kg and able to tolerate a minimum inflow volume of 100 mL. The primary objective is to determine whether patients achieve a total weekly Kt/Vurea ≥ 1.8.
Official title: Efficacy and Tolerability of the APD Treatment of Toddlers and Newborns With the Silencia PD Cycler
Key Details
Gender
All
Age Range
0 Months - Any
Study Type
INTERVENTIONAL
Enrollment
13
Start Date
2026-01
Completion Date
2026-11
Last Updated
2025-06-04
Healthy Volunteers
No
Conditions
Interventions
Treatment with the pedriatic mode of the APD cycler
Patients weighing less than 20 kg will be treated for 4 weeks with APD using the PAED mode of the Silencia PD cycler